Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
.11 and Up!
»
NRGX Gene therapy
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by BooDog: [QB] News for 'NRGX' - (DJ Corriente Advisors Reports 28.5% Neurologix Stake >NRGX) DOW JONES NEWSWIRES Corriente Advisors LLC on Thursday reported holding a 28.5% stake in Neurologix Inc. (NRGX), according to a Schedule 13D filed with the Securities and Exchange Commission. The Fort Worth, Texas-based investor beneficially owns about 10.78 million shares of Neurologix, a Fort Lee, N.J.-based biotech company. Corriente said it acquired the shares for investment and believes they are "undervalued" and represent "an attractive investment opportunity." Neurologix is engaged in the research and development of gene therapies for the brain and central nervous system. The company's shares closed Wednesday at $1.10 each -Brian Coyle, Dow Jones Newswires; 202-862-3545 (END) Dow Jones Newswires November 29, 2007 06:55 ET (11:55 GMT) Copyright (c) 2007 Dow Jones & Company, Inc.- - 06 55 AM EST 11-29-07 [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2